• The Recorder | News

    New Prop 65 Lawsuit Filed Against J&J, Others Over Talc's Safety

    January 29, 2020

    The lawsuit, filed by Simmons Hanly Conroy, comes six months after the Lanier Law Firm voluntarily dismissed a similar Prop 65 suit against Johnson & Johnson and names more than a dozen defendants, including CVS and Bausch Health.

  • Law.com | Research

    Investors Targeted Lawsuits at Cannabis Companies in 2019, Report Finds

    January 21, 2020

    According to NERA Economic Consulting's annual report, released on Tuesday, six lawsuits alleged securities fraud against cannabis companies. There was only one in 2018.

  • Law.com | Analysis

    Robbins Geller and Simpson Thacher Hammer Out $1.2B Valeant Settlement

    December 17, 2019

    Plaintiffs alleged the company now known as Bausch Health had "formed a secret network of so-called specialty pharmacies to artificially inflate the sale of Valeant drugs using a variety of fraudulent practices."

  • Litigation Daily | Commentary

    Daily Dicta: Robbins Geller; Simpson Thacher Hammer Out $1.2B Valeant Settlement

    December 17, 2019

    "Resolving this action enables Bausch Health to close the door on one of the more meaningful and unpredictable liabilities associated with the legacy Valeant era," said the company's CEO.

  • Edwards v. Sequoia Fund Inc.

    Publication Date: 2019-09-13
    Practice Area: Securities Litigation
    Industry: Investments and Investment Advisory
    Court: U.S. Court of Appeals for the Second Circuit
    Judge: Circuit Judge Denny Chin
    Attorneys: For plaintiff: For Plaintiffs-Appellants: Alan M. Pollack, on the brief, Felicia S. Ennis, Robinson Brog Leinwand Greene Genovese & Gluck, P.C., New York, New York, and Raymond Farrow and Mark A. Griffin, Keller Rohrback L.L.P., Seattle, Washington, on the brief.
    for defendant: For Defendant-Appellee: Amy D. Roy and Lee S. Gayer, on the brief, Robert A. Skinner, Ropes & Gray LLP, Boston, Massachusetts, and New York, New York.

    Case Number: 18-3467-cv

    SEC's 1998 Guidance Allows Fund's 'Passive Increase' Concentration of Assets in Industry

  • National Law Journal | News

    Valeant, Mylan Go to War Over Katten Disqualification

    September 13, 2018

    Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.

  • Litigation Daily | News

    Mylan, Valeant Go to War Over Katten Disqualification

    September 13, 2018

    Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.

  • Hound Partners Offshore Fund LP v. Valeant Pharms. Int'l Inc.

    Publication Date: 2018-05-03
    Practice Area: Securities Litigation
    Industry: Investments and Investment Advisory
    Court: U.S. District Court for the Southern District of New York, U.S. - SDNY
    Judge: District Judge Denise Cote
    Attorneys: For plaintiff: For the plaintiffs: Chad Johnson, Jennifer Barrett, Steig D. Olson, Rollo C. Baker, Kathryn Bonacorsi, Jesse Bernstein, Quinn Emanuel Urquhart & Sullivan, LLP, New York, New York.
    for defendant: For defendants Valeant Pharmaceuticals International, Inc., Robert L. Rosiello, Ari S. Kellen, Ronald H. Farmer, Colleen Goggins, Robert A. Ingram, Anders Lönner, Theo Melas-Kyriaza, Robert N. Power, Norma Provencio, and Katharine B. Stevenson: Paul C. Curnin, Jonathan K. Youngwood, Craig S. Waldman, Daniel J. Stujenske, Dean McGee, Simpson Thacher & Bartlett LLP, New York, New York.; For defendants Deutsche Bank Securities, Inc., HSBC Securities (USA) Inc., MUFG Securities Americas Inc., DNB Markets Inc., Barclays Capital Inc. Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, and Suntrust Robinson Humphrey, Inc.: Richard A. Rosen, Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York.; For defendant Tanya Carro: William J. Schwartz, Laura G. Birger, Cooley LLP, New York, New York.; For defendant Deborah Jorn: Cara David, Barry A. Bohrer, Michael L. Yaeger, Schulte Roth & Zabel LLP, New York, New York.; For defendant J. Michael Pearson: Holly S. Wintermute, Debevoise & Plimpton LLP, New York, New York.; Jonathan R. Tuttle, Ada F. Johnson, Debevoise & Plimpton LLP, Washington, D.C.; For defendant PricewaterhouseCoopers LLP: James J. Capra, King & Spalding LLP, New York, New York.; Kenneth Y. Turnbull, King & Spalding LLP, Washington, D.C.; For defendant Howard B. Schiller: Robert Y. Sperling, Joseph L. Motto, Winston & Strawn LLP, Chicago, Illinois.

    Case Number: 18 cv 76

    Securities Fraud Suit Could Have Been Brought in District of New Jersey, Granted Transfer

  • Daily Business Review | News

    Florida Suing Drug Company Over Stock Losses

    November 8, 2017

    Acting on its own, Florida will take on an international pharmaceutical company, alleging the state's pension fund lost more than $62 million in stock…

  • The Legal Intelligencer | News

    Eye Drop Class Action Revived by Third Circuit

    October 18, 2017

    A putative class action over the size of eye medicine drops dismissed by a federal judge for lack of standing has been revived by the U.S. Court of Appeals for the Third Circuit.